MedTrace Logo

Artegraft Versus Propaten Dialysis Grafts

NCT02099344 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2019-05-15

Study results available
· View outcomes & findings →

Summary

Compare Artegraft and Propaten grafts for use in dialysis access to see if one performs better than the other. How long each one lasts until a complication arises or until the graft is no longer used will be compared.

The study hypothesis is that the Artegraft, being an actual blood vessel, will work better than the manufactured Propaten graft.

Conditions

  • ESRD
  • Renal Failure

Interventions

DEVICE

Artegraft

Surgical placement of graft for hemodialysis access

DEVICE

Propaten

Surgical placement of graft for hemodialysis access

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Earl Schuman, MD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02099344 on ClinicalTrials.gov